Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy
Authors:
- 1 July 2021
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 334, 58-64
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 HL147064)
This publication has 18 references indexed in Scilit:
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingEuropean Heart Journal - Cardiovascular Imaging, 2015
- Innovative research methods for studying treatments for rare diseases: methodological reviewBMJ, 2014
- Ventricular Arrhythmias in the North American Multidisciplinary Study of ARVCJACC, 2014
- Incidence and Predictors of Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Undergoing Implantable Cardioverter-Defibrillator Implantation for Primary PreventionJACC, 2011
- Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/DysplasiaCirculation, 2010
- Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right Ventricular CardiomyopathyJACC, 2009
- Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer eventsBiostatistics, 2006
- Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/DysplasiaCirculation, 2003
- Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.Circulation, 1992
- Right Ventricular Cardiomyopathy and Sudden Death in Young PeopleNew England Journal of Medicine, 1988